Visible results in 88% of recorded treatment sessions.
Dema Health, Inc. is independently engaging with individuals living with secondary lymphedema for Patient Perception Efficiency Trials, prior to market launch. The first in-home trial was completed in May 2026 and yielded overwhelmingly positive results.